G Nair1, M Absinta, D S Reich. 1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Abstract
BACKGROUND AND PURPOSE: Spinal cord lesions are highly prevalent in MS, and their visualization can help both in diagnosis and patient follow-up. However, the sensitivity of MR imaging to spinal cord lesions remains poor, primarily because of suboptimal contrast between lesions and a normal-appearing cord. Here, we propose an optimized 3D MPRAGE sequence for improved detection of MS lesions in the spinal cord at 3T. MATERIALS AND METHODS: Images were acquired by use of T2 FSE, STIR, T1-gradient recalled-echo (for T1 mapping), and T1-MPRAGE in the sagittal plane, and T2*-weighted scans in the axial plane, on 40 patients with MS and 7 healthy volunteers. Two observers qualitatively evaluated the images for lesion conspicuity. Lesions seen between the C1 and C4 segments in 10 randomly selected patients with MS were further evaluated quantitatively for contrast-to-noise ratio between the lesion and normal-appearing cord, and for lesion burden. RESULTS: Spinal cord lesions were more conspicuous on the optimized T1-MPRAGE sequence than on any other sequence tested. Detailed analysis revealed that lesions were almost 3 times more conspicuous (P < .01), and the total lesion volume was 2 times greater (P < .05, n=10), in the T1-MPRAGE sequence compared with the standard STIR sequence. Correlation of clinical disability (Expanded Disability Status Score) with lesion load from each sequence also demonstrated the importance of the improved lesion conspicuity with T1-MPRAGE. CONCLUSIONS: The optimized T1-MPRAGE sequence described here improves the reliability of lesion visualization and estimation of lesion burden, especially when used in conjunction with other well-established clinical sequences.
RCT Entities:
BACKGROUND AND PURPOSE:Spinal cord lesions are highly prevalent in MS, and their visualization can help both in diagnosis and patient follow-up. However, the sensitivity of MR imaging to spinal cord lesions remains poor, primarily because of suboptimal contrast between lesions and a normal-appearing cord. Here, we propose an optimized 3D MPRAGE sequence for improved detection of MS lesions in the spinal cord at 3T. MATERIALS AND METHODS: Images were acquired by use of T2 FSE, STIR, T1-gradient recalled-echo (for T1 mapping), and T1-MPRAGE in the sagittal plane, and T2*-weighted scans in the axial plane, on 40 patients with MS and 7 healthy volunteers. Two observers qualitatively evaluated the images for lesion conspicuity. Lesions seen between the C1 and C4 segments in 10 randomly selected patients with MS were further evaluated quantitatively for contrast-to-noise ratio between the lesion and normal-appearing cord, and for lesion burden. RESULTS:Spinal cord lesions were more conspicuous on the optimized T1-MPRAGE sequence than on any other sequence tested. Detailed analysis revealed that lesions were almost 3 times more conspicuous (P < .01), and the total lesion volume was 2 times greater (P < .05, n=10), in the T1-MPRAGE sequence compared with the standard STIR sequence. Correlation of clinical disability (Expanded Disability Status Score) with lesion load from each sequence also demonstrated the importance of the improved lesion conspicuity with T1-MPRAGE. CONCLUSIONS: The optimized T1-MPRAGE sequence described here improves the reliability of lesion visualization and estimation of lesion burden, especially when used in conjunction with other well-established clinical sequences.
Authors: J H Simon; D Li; A Traboulsee; P K Coyle; D L Arnold; F Barkhof; J A Frank; R Grossman; D W Paty; E W Radue; J S Wolinsky Journal: AJNR Am J Neuroradiol Date: 2006-02 Impact factor: 3.825
Authors: Nancy Martin; David Malfair; Yinshan Zhao; David Li; Anthony Traboulsee; Donna Lang; Alexandra Talia Vertinsky Journal: AJR Am J Roentgenol Date: 2012-07 Impact factor: 3.959
Authors: G J Lycklama à Nijeholt; F Barkhof; P Scheltens; J A Castelijns; H Adèr; J H van Waesberghe; C Polman; S J Jongen; J Valk Journal: AJNR Am J Neuroradiol Date: 1997 Jun-Jul Impact factor: 3.825
Authors: J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns Journal: Neurology Date: 2004-01-27 Impact factor: 9.910
Authors: S Galler; J-P Stellmann; K L Young; D Kutzner; C Heesen; J Fiehler; S Siemonsen Journal: AJNR Am J Neuroradiol Date: 2016-01-07 Impact factor: 3.825
Authors: Winston Liu; Govind Nair; Luisa Vuolo; Anshika Bakshi; Raya Massoud; Daniel S Reich; Steven Jacobson Journal: Ann Neurol Date: 2014-07-22 Impact factor: 10.422
Authors: Adrienne N Dula; Siddharama Pawate; Richard D Dortch; Robert L Barry; Kristen M George-Durrett; Bailey D Lyttle; Lindsey M Dethrage; John C Gore; Seth A Smith Journal: Mult Scler Date: 2015-07-24 Impact factor: 6.312
Authors: S Suthiphosuwan; P Sati; M Guenette; X Montalban; D S Reich; A Bharatha; J Oh Journal: AJNR Am J Neuroradiol Date: 2019-04-18 Impact factor: 3.825
Authors: P Alcaide-Leon; A Pauranik; L Alshafai; S Rawal; J Oh; W Montanera; G Leung; A Bharatha Journal: AJNR Am J Neuroradiol Date: 2016-01-21 Impact factor: 3.825